Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport

FEBS Lett. 2008 Jun 25;582(15):2303-2308. doi: 10.1016/j.febslet.2008.05.034. Epub 2008 Jun 2.

Abstract

Neurofilaments are synthesised in neuronal cell bodies and then transported through axons. Damage to neurofilament transport is seen in amyotrophic lateral sclerosis (ALS). Here, we show that PKN1, a neurofilament head-rod domain kinase is cleaved and activated in SOD1G93A transgenic mice that are a model of ALS. Moreover, we demonstrate that glutamate, a proposed toxic mechanism in ALS leads to caspase cleavage and disruption of PKN1 in neurons. Finally, we demonstrate that a cleaved form of PKN1 but not wild-type PKN1 disrupts neurofilament organisation and axonal transport. Thus, deregulation of PKN1 may contribute to the pathogenic process in ALS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / enzymology*
  • Amyotrophic Lateral Sclerosis / etiology
  • Amyotrophic Lateral Sclerosis / genetics
  • Animals
  • Axonal Transport* / genetics
  • Caspase 3 / metabolism
  • Disease Models, Animal
  • Glutamic Acid / toxicity
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Neurofilament Proteins / metabolism*
  • Neurofilament Proteins / ultrastructure*
  • Neurons / drug effects
  • Neurons / enzymology
  • Neurons / ultrastructure
  • Protein Kinase C / genetics
  • Protein Kinase C / metabolism*
  • Rats
  • Spinal Cord / metabolism
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase-1

Substances

  • Neurofilament Proteins
  • SOD1 protein, human
  • Glutamic Acid
  • Sod1 protein, mouse
  • Sod1 protein, rat
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • protein kinase N
  • Protein Kinase C
  • Caspase 3